全文获取类型
收费全文 | 49521篇 |
免费 | 4497篇 |
国内免费 | 1803篇 |
专业分类
耳鼻咽喉 | 305篇 |
儿科学 | 911篇 |
妇产科学 | 1373篇 |
基础医学 | 10109篇 |
口腔科学 | 1728篇 |
临床医学 | 4257篇 |
内科学 | 5485篇 |
皮肤病学 | 1249篇 |
神经病学 | 2892篇 |
特种医学 | 1092篇 |
外国民族医学 | 20篇 |
外科学 | 3502篇 |
综合类 | 7488篇 |
现状与发展 | 12篇 |
一般理论 | 12篇 |
预防医学 | 3541篇 |
眼科学 | 953篇 |
药学 | 6224篇 |
21篇 | |
中国医学 | 1294篇 |
肿瘤学 | 3353篇 |
出版年
2023年 | 527篇 |
2022年 | 721篇 |
2021年 | 1599篇 |
2020年 | 1387篇 |
2019年 | 1445篇 |
2018年 | 1409篇 |
2017年 | 1545篇 |
2016年 | 1633篇 |
2015年 | 1671篇 |
2014年 | 2706篇 |
2013年 | 3662篇 |
2012年 | 2677篇 |
2011年 | 2942篇 |
2010年 | 2506篇 |
2009年 | 2280篇 |
2008年 | 2261篇 |
2007年 | 2414篇 |
2006年 | 2220篇 |
2005年 | 1996篇 |
2004年 | 1867篇 |
2003年 | 1696篇 |
2002年 | 1427篇 |
2001年 | 1256篇 |
2000年 | 1065篇 |
1999年 | 958篇 |
1998年 | 930篇 |
1997年 | 878篇 |
1996年 | 834篇 |
1995年 | 785篇 |
1994年 | 669篇 |
1993年 | 644篇 |
1992年 | 566篇 |
1991年 | 509篇 |
1990年 | 395篇 |
1989年 | 403篇 |
1988年 | 341篇 |
1987年 | 259篇 |
1986年 | 234篇 |
1985年 | 477篇 |
1984年 | 391篇 |
1983年 | 306篇 |
1982年 | 319篇 |
1981年 | 257篇 |
1980年 | 186篇 |
1979年 | 127篇 |
1978年 | 120篇 |
1977年 | 73篇 |
1976年 | 71篇 |
1975年 | 45篇 |
1974年 | 37篇 |
排序方式: 共有10000条查询结果,搜索用时 113 毫秒
11.
《Bulletin du cancer》2019,106(4):389-394
12.
13.
《Vaccine》2021,39(26):3498-3508
Adenovirus infections are a major cause of epidemic keratoconjunctivitis (EKC), which can lead to corneal subepithelial infiltrates and multifocal corneal opacity. In the current study, we investigated the use of an E1/E3-deleted adenovirus serotype 5 (Ad5) vector as a vaccine administered intramuscularly (IM) or intranasally (IN) against subsequent challenges with a luciferase-expressing Ad5 (Ad5-Luci) vector via eyedrop. We evaluated the adaptive immune response to Ad5 vector vaccination and confirmed a robust polyfunctional CD8 T cell response in splenic cells. Neutralizing Ad5 antibodies were also measured in the sera of vaccinated mice as well as Ad5 antibody in the eye wash solutions. Upon challenge with Ad5-Luci vector 8 weeks post the primary immunization, transduction was significantly reduced by > 70% in the vaccinated mice, which was slightly better in IM- vs. that in IN-vaccinated animals. Resistance to subsequent challenge was observed 10 months post primary IM vaccination, with sustained reduction up to 60% in the Ad5-Luci vector transduction. Passive immunization of naive mice with antisera from IM to vaccinated mice subsequently challenged with the Ad5-Luci vector resulted in approximately 40% loss in transduction efficiency. Furthermore, the mice that received IM immunization with or without CD8 T cell depletion showed > 40% and 70% reductions, respectively, in Ad8 genomic copies after Ad8 topical challenge. We conclude that Ad-vector vaccination successfully induced an adaptive immune response that prevented subsequent Ad transduction in the cornea and conjunctiva-associated tissues in a mouse model of adenovirus keratoconjunctivitis, and that both cellular and humoral immunity play an important role in preventing Ad transduction. 相似文献
14.
Iria Montero Prez Laura Rodríguez‐Pazos Adriana lvarez‐Prez MªMercedes Pereiro Ferreirs Carlos Aliste Jose Manuel Suarez‐Pearanda Jaime Toribio 《Journal of cutaneous pathology》2015,42(11):889-893
Classical Kaposi sarcoma (KS) usually appears on lower extremities accompanied or preceded by local lymphedema. However, the development in areas of chronic lymphedema of the arms following mastectomy, mimicking a Stewart–Treves syndrome, has rarely been described. We report an 81‐year‐old woman who developed multiple, erythematous to purple tumors, located on areas of post mastectomy lymphedema. Histopathological examination evidenced several dermal nodules formed by spindle‐shaped cells that delimitated slit‐like vascular spaces with some red cell extravasation. Immunohistochemically, the human herpesvirus type 8 (HHV‐8) latent nuclear antigen‐1 was detected in the nuclei of most tumoral cells confirming the diagnosis of KS. Lymphedema could promote the development of certain tumors by altering immunocompetence. Although angiosarcoma (AS) is the most frequent neoplasia arising in the setting of chronic lymphedema, other tumors such as benign lymphangiomatous papules (BLAP) or KS can also develop in lymphedematous limbs. It is important to establish the difference between AS and KS because their prognosis and treatment are very different. Identification by immunohistochemistry of HHV‐8 is useful for the distinction between KS and AS or BLAP. 相似文献
15.
16.
17.
吉兰―巴雷综合征(GBS)是一种以快速进行性四肢麻木无力为特点的急性炎性脱髓鞘性多发性多神经根神经病。随着外源性神经节苷脂在临床的广泛应用,该药引起的副作用也逐渐显现,外源性神经节苷脂相关性GBS是其最严重的并发症,临床上主要表现为轴索型GBS,以四肢弛缓性瘫痪为首发症状,表现为急性、严重且快速进展的周围神经受累,较其他轴索型GBS病情重,恢复时间长,预后差。目前发病机制尚不明确。静脉注射人免疫球蛋白是其具有循证医学证据的治疗方法,目前已取代血浆置换成为GBS首选治疗方法,推荐剂量为0.4 g/(kg·d),连续静滴5 d,大剂量激素治疗的效果还有待进一步探讨。早发现、早诊断、尽早停用外源性神经节苷脂、及时应用人血免疫球蛋白冲击治疗和康复治疗,可改善预后。 相似文献
18.
Frédéric Janvier Deborah Delaune Thomas Poyot Eric Valade Audrey Mérens Pierre E. Rollin Vincent Foissaud 《Emerging infectious diseases》2016,22(2):292-294
We evaluated RNA stability of Ebola virus in EDTA blood and urine samples collected from infected patients and stored in West Africa’s environmental conditions. In blood, RNA was stable for at least 18 days when initial cycle threshold values were <30, but in urine, RNA degradation occurred more quickly. 相似文献
19.
《药学学报(英文版)》2020,10(7):1294-1308
A great challenge in multi-targeting drug discovery is to identify drug-like lead compounds with therapeutic advantages over single target inhibitors and drug combinations. Inspired by our previous efforts in designing antitumor evodiamine derivatives, herein selective histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) dual inhibitors were successfully identified, which showed potent in vitro and in vivo antitumor potency. Particularly, compound 30a was orally active and possessed excellent in vivo antitumor activity in the HCT116 xenograft model (TGI = 75.2%, 150 mg/kg, p.o.) without significant toxicity, which was more potent than HDAC inhibitor vorinostat, TOP inhibitor evodiamine and their combination. Taken together, this study highlights the therapeutic advantages of evodiamine-based HDAC1/TOP2 dual inhibitors and provides valuable leads for the development of novel multi-targeting antitumor agents. 相似文献
20.
目的研究快速成型(RP)技术辅助下制作的个体化假体复合珊瑚羟基磷灰石(CHA)、重组人骨形成蛋白2(rhBMP-2)修复兔下颌骨缺损的成骨效果。
方法以27只新西兰大白兔为实验对象,随机数字表法平均分成3组(每组9只),全部建立下颌骨连续性缺损模型,并在兔下颌骨缺损区分别植入个体化假体+自体骨(A组)、个体化假体+CHA(B组)、个体化假体+CHA+rhBMP-2(C组)。分别于术后4、12、24周3个时间点处死动物取材,进行大体标本观察,以及骨钙素(OC)、Ⅰ型胶原(COL-1)的免疫组化观察,分别比较各组修复骨缺损的能力,并对实验数据进行重复测量设计资料的单因素方差分析。
结果术后24周各组实验兔外形均对称,通过OC及COL-1的吸光度检测,骨缺损区均有大量新骨形成,A组(0.537 ± 0.010)、C组(0.530 ± 0.010)可见大量骨小梁及编织骨结构,缺损区的新骨OC、COL-1的免疫组化观察基本一致,差异无统计学意义(t = 0.007,P>0.05);但A组强于B组(0.415 ± 0.009,t = 0.122,P<0.001);C组也强于B组(t = 0.121,P<0.001),差异均有统计学意义。
结论在兔下颌骨缺损修复中,通过RP技术和组织工程技术相结合,CHA复合rhBMP-2后成骨能力明显增强,成骨效能肯定,为后期的临床应用提供可靠的实验基础。 相似文献